Criticare Systems 10-Q 2005 Q3 Quarterly report

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________

Form 10-Q

__X__ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934

For the quarterly period endedMarch 31, 2005

OR

_____ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission file number  1-31943

CRITICARE SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware	39-1501563
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

20925 Crossroads Circle, Suite 100, Waukesha, Wisconsin	53186
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number including area code(262) 798-8282

N/A

Former name, former address and former fiscal year, if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes    X      No          

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes           No     X   

Number of shares outstanding of each class of the registrant's classes of common stock as of March 31, 2005: Class A Common Stock 11,581,766 shares.

CRITICARE SYSTEMS, INC.

CONSOLIDATED BALANCE SHEETS

MARCH 31, 2005 AND JUNE 30, 2004

(UNAUDITED)

ASSETS	March 31,2005			June 30,2004
CURRENT ASSETS:
Cash and cash equivalents	$	3,731,417		$	3,738,825
Accounts receivable, less allowance for doubtful accounts
of $300,000 and $260,000, respectively		6,345,700			6,489,884
Other receivables		446,233			359,806
Inventories		5,478,645			6,418,135
Prepaid expenses		190,913			364,375
Total current assets		16,192,908			17,371,025
Property, plant and equipment - net		1,640,645			2,094,330
License rights and patents - net		71,733			76,985
TOTAL ASSETS	$	17,905,286		$	19,542,340
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable	$	2,844,321		$	3,237,405
Accrued liabilities:
Compensation and commissions		844,926			863,113
Product warranties		486,000			444,000
Liability under guarantees		—			490,000
Out of court settlement		—			200,000
Obligations under capital lease		61,442			57,712
Other		146,731			174,395
Total current liabilities		4,383,420			5,466,625
LONG-TERM LIABILITIES:
Obligations under capital lease		218,211			264,770
Other long-term obligations		13,171			21,646
Total long-term liabilities		231,382			286,416
TOTAL LIABILITIES		4,614,802			5,753,041
STOCKHOLDERS' EQUITY:
Preferred stock - $.04 par value, 500,000 shares authorized, no shares issued or outstanding		—			—
Common stock - $.04 par value, 15,000,000 shares authorized, 11,696,649 and 11,574,749 shares issued, respectively, and 11,581,766 and 11,450,021 shares outstanding, respectively
		467,865			462,990
Additional paid-in capital		24,237,384			23,965,900
Common stock held in treasury (114,883 and 124,728 shares, respectively)		(391,099	)		(409,439	)
Retained earnings (accumulated deficit)		(11,020,184	)		(10,226,670	)
Cumulative translation adjustment		(3,482	)		(3,482	)
Total stockholders' equity		13,290,484			13,789,299
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	17,905,286		$	19,542,340

See notes to consolidated financial statements.

2

CRITICARE SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

NINE MONTHS ENDED MARCH 31, 2005 AND 2004

(UNAUDITED)

	2005			2004
NET SALES	$	18,760,733		$	21,923,864
COST OF GOODS SOLD		11,357,934			12,855,828
GROSS PROFIT		7,402,799			9,068,036
OPERATING EXPENSES:
Sales and marketing		4,231,575			5,316,293
Research, development and engineering		1,899,752			1,810,732
Administrative		2,140,193			2,484,791
Total		8,271,520			9,611,816
LOSS FROM OPERATIONS		(868,721	)		(543,780	)
OTHER INCOME (EXPENSE):
Interest expense		(23,091	)		—
Interest income		38,311			29,496
Other income		59,987			122,371
Total		75,207			151,867
LOSS BEFORE INCOME TAXES		(793,514	)		(391,913	)
INCOME TAX PROVISION		—			—
NET LOSS	$	(793,514	)	$	(391,913	)
NET LOSS PER COMMON SHARE:
Basic	$	(0.07	)	$	(0.04	)
Diluted	$	(0.07	)	$	(0.04	)
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING:
Basic		11,469,066			11,173,768
Diluted		11,469,066			11,173,768

See notes to consolidated financial statements.

3

CRITICARE SYSTEMS, INC.

CONSOLIDATED INCOME STATEMENTS

THREE MONTHS ENDED MARCH 31, 2005 AND 2004

(UNAUDITED)

	2005			2004
NET SALES	$	6,054,370		$	6,571,171
COST OF GOODS SOLD		3,624,399			3,762,149
GROSS PROFIT		2,429,971			2,809,022
OPERATING EXPENSES:
Sales and marketing		1,358,781			1,944,077
Research, development and engineering		724,817			586,419
Administrative		649,823			759,740
Total		2,733,421			3,290,236
LOSS FROM OPERATIONS		(303,450	)		(481,214	)
OTHER INCOME (EXPENSE):
Interest expense		(6,064	)		—
Interest income		18,238			8,748
Other income		46,405			59,859
Total		58,579			68,607
LOSS BEFORE INCOME TAXES		(244,871	)		(412,607	)
INCOME TAX PROVISION		—			—
NET LOSS	$	(244,871	)	$	(412,607	)
NET LOSS PER COMMON SHARE:
Basic	$	(0.02	)	$	(0.04	)
Diluted	$	(0.02	)	$	(0.04	)
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING:
Basic		11,501,085			11,326,283
Diluted		11,501,085			11,326,283

See notes to consolidated financial statements.

4

CRITICARE SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

NINE MONTHS ENDED MARCH 31, 2005 AND 2004

(UNAUDITED)

	2005			2004
OPERATING ACTIVITIES:
Net loss	$	(793,514	)	$	(391,913	)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation		448,691			442,910
Amortization		5,252			5,251
Provision for doubtful accounts		40,000			80,602
Provision for obsolete inventory		340,000			429,073
Changes in assets and liabilities:
Accounts receivable		104,184			(1,295,961	)
Other receivables		(86,427	)		57,073
Inventories		683,561			(400,094	)
Prepaid expenses		173,462			28,939
Accounts payable		(393,084	)		695,729
Accrued liabilities		(702,326	)		114,555
Net cash used in operating activities		(180,201	)		(233,836	)
INVESTING ACTIVITIES:
Purchases of property, plant and equipment, net		(79,078	)		(324,360	)
Net cash used in investing activities		(79,078	)		(324,360	)
FINANCING ACTIVITIES:
Retirement of obligations under capital lease		(42,828	)		—
Proceeds from issuance of common stock		294,699			827,059
Net cash provided by financing activities		251,871			827,059
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		(7,408	)		268,863
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		3,738,825			3,716,446
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	3,731,417		$	3,985,309
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for:
Income taxes paid-net	$	3,444		$	3,053
Interest	$	23,091			—

See notes to consolidated financial statements.

5

CRITICARE SYSTEMS, INC.

Condensed Notes to Consolidated Financial Statements

(Unaudited)

1. Basis of Presentation

The accompanying unaudited financial statements have been prepared by Criticare Systems, Inc. (the "Company") pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and, in the opinion of the Company, include all adjustments necessary for a fair statement of results for each period shown. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such SEC rules and regulations. The Company believes that the disclosures made are adequate to prevent the financial information given from being misleading. It is suggested that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company's latest annual report and previously filed Form 10-K. The three and nine month results represent past performance, and are not necessarily indicative of results for an entire year. Certain amounts from the fiscal 2004 financial statements have been reclassified to conform to the 2005 presentation.

2. Inventory Valuation

Inventory is stated at the lower of cost or market, with cost determined on the first-in, first-out method. Components of inventory consisted of the following at March 31, 2005 and June 30, 2004, respectively:

	March 31, 2005		June 30, 2004
Component parts	$	1,992,358	$	1,988,414
Work in process		1,159,774		781,156
Finished units		3,276,513		4,258,565
Total inventories		6,428,645		7,028,135
Less: reserve for obsolescence		950,000		610,000
Net inventory	$	5,478,645	$	6,418,135

3. Property, Plant and Equipment

Property, plant and equipment consist of the following:

	March 31, 2005			June 30, 2004
Machinery and equipment	$	2,768,721		$	2,675,093
Furniture and fixtures		889,108			937,906
Leasehold improvements		218,423			218,423
Production tooling		2,064,866			2,030,618
Demonstration and loaner monitors		808,209			945,339
Property, plant and equipment - cost		6,749,327			6,807,379
Less: accumulated depreciation		(5,108,682	)		(4,713,049	)
Property, plant and equipment - net	$	1,640,645		$	2,094,330

6

4. Stock Options

The Company has adopted the disclosure-only provisions of SFAS No. 123, “Accounting for Stock-Based Compensation” and SFAS No. 148, “Accounting for Stock-Based Compensation—Transition and Disclosure”. If the Company had elected to recognize compensation cost for the options granted for the three months and nine months ended March 31, 2005 and 2004, consistent with the method prescribed by SFAS No. 123, net loss and net loss per share would have been changed to the pro forma amounts indicated below:

	Three Months Ended						Nine Months Ended
	2005			2004			2005			2004
Net income (loss) - as reported	$	(244,871	)	$	(412,607	)	$	(793,514	)	$	(391,913	)
Net income (loss) - pro forma	$	(356,989	)	$	(431,118	)	$	(1,129,867	)	$	(447,446	)
Basic net income (loss) per share - as reported	$	(0.02	)	$	(0.04	)	$	(0.07	)	$	(0.04	)
Diluted net income (loss) per share - as reported	$	(0.02	)	$	(0.04	)	$	(0.07	)	$	(0.04	)
Basic net income (loss) per share - pro forma	$	(0.03	)	$	(0.04	)	$	(0.10	)	$	(0.04	)
Diluted net income (loss) per share - pro forma	$	(0.03	)	$	(0.04	)	$	(0.10	)	$	(0.04	)

For the three months ended March 31, 2005, the Company granted options totaling 20,000 shares at a weighted average exercise price of $3.70, which are valued at $55,724. For the nine months ended March 31, 2005, the Company granted options totaling 87,000 shares at a weighted average exercise price of $2.89, which are valued at $186,047. The fair value of stock options used to compute pro forma net loss and net loss per share is the estimated present value at the grant date using the Black-Scholes option-pricing model.

5. Income Taxes

No income tax provision has been made in the consolidated statements of operations due to federal and state net operating loss carry forwards that will be utilized to offset taxable income earned. At March 31, 2005, the Company had federal net operating loss carry forwards of approximately $16,980,000 (which expire from 2008 through 2024) and state net operating loss carry forwards of approximately $11,476,000 (which expire from 2004 through 2019) available to offset future taxable income. The Company has recorded a valuation allowance to offset the related deferred income tax assets arising from these net loss carry forwards due to the uncertainty of realizing the benefits of these assets in future years.

6. Line of Credit Facility

At March 31, 2005, the Company had a $1,000,000 demand line of credit with a commercial bank, which matures on November 15, 2005, to meet its short-term borrowing needs. Borrowings against the line are payable on demand with interest payable monthly at the bank’s reference rate, plus 0.25% (6.00% as of March 31, 2005). As of March 31, 2005 and 2004, there were no borrowings against the line. Borrowings under the line of credit facility are collateralized by substantially all assets of the Company. The credit facility has no loan covenant restrictions.

7

CRITICARE SYSTEMS, INC.

Management's Discussion and Analysis of

Results of Operations and Financial Condition

Nine Months Ended March 31, 2005 and 2004

Results of Operations

Net sales of $18,760,733 for the nine months ended March 31, 2005 were down 14.4% from $21,923,864 for the same period in fiscal 2004. A 30.5% decrease in the number of units shipped was partially offset by a 13.5% increase in the average sales price per unit and a 20.7% increase in accessory sales in the current year. The reduced sales were the result of a $1,447,180 decrease in sales to Alaris Medical Systems (“Alaris”), formerly our largest OEM partner, a $1,643,251 decrease in domestic sales and a $798,963 decrease in international sales during the nine month period. Alaris was acquired by Cardinal Health in 2004. Subsequently, Cardinal Health made the decision to exit from vital signs monitor sales activities, since those products no longer fit within its core business strategy. The international sales decrease was the result of a $1,130,250 order shipped in December 2003, which increased international sales for the nine months ended March 31, 2004, without a comparable sale in the nine months ended March 31, 2005. The OEM sales decrease was partially offset by $790,122 in sales to Medrad, our newest OEM partner for medical imaging applications. The decrease in domestic sales was due in part to lost sales following the cancellation of two oral surgery shows in Florida and one oral surgery show in Louisiana as a result of the hurricanes during the first quarter.

The gross profit percentage of 39.5% for the nine months ended March 31, 2005 decreased from 41.4% for the same period in fiscal 2004. The reduced margins in the current period were mainly a result of the decreased manufacturing overhead absorption, due to the decrease in the number of units shipped against relatively fixed overhead costs.

Operating expenses for the nine months ended March 31, 2005 decreased $1,340,296 from the same period in fiscal 2004. The decrease of $1,084,718 in sales and marketing expenses was due mainly to an $388,660 decrease in the commissions earned by dealers and employees, a decrease of $230,335 in advertising, trade shows and sales promotion spending and a $244,394 decrease in operating supplies. Research, development and engineering expenses increased by $89,020. Administrative expenses decreased by $344,598 mainly due to the cost containment efforts such as reducing consulting expenses by $107,300, reducing accounting fees by $54,607, reducing investor expenses by $62,768 and reducing business insurance premium expense by $54,921.

Total other income for the nine months ended March 31, 2005 decreased $76,660 from the same period in fiscal 2004. This reduction was mainly caused by interest expense of $23,091 primarily for a new capital lease (which began in April 2004) and $45,000 paid by the Company for the settlement with the U.S. government for import/export regulation issues.

The $1,665,237 reduction in gross profit and the decrease in other income of $76,660, partially offset by the reduction in operating expenses of $1,340,296, resulted in a net loss of $(793,514) for the nine months ended March 31, 2005 as compared to a net loss of $(391,913) for the same period in fiscal 2004.

8

CRITICARE SYSTEMS, INC.

Management's Discussion and Analysis of

Results of Operations and Financial Condition

Three Months Ended March 31, 2005 and 2004

Results of Operations

Net sales of $6,054,370 for the three months ended March 31, 2005 were down 7.9% from $6,571,171 for the same period in fiscal 2004. A 22.5% decrease in the number of units shipped and a 0.98% decrease in the average sales price per unit, due to the product mix, were partially offset by a 45.3% increase in accessory sales in the current period. The reduced sales were the result of a $1,007,611 decrease in domestic sales, a $258,846 decrease in international sales and a $204,925 decrease in sales to Alaris, formerly our largest OEM partner, in the current period. The sales decrease was partially offset by $503,128 in sales to Medrad, our newest OEM partner for medical imaging applications, and $275,936 in government sales. Additionally, OEM sales to customers other than Medrad and Alaris increased by $107,227 in the current period.

The gross profit percentage of 40.1% for the three months ended March 31, 2005 decreased from 42.7% for the same period in fiscal 2004. The reduced margins in the third quarter were mainly due to the decreased manufacturing overhead absorption, due to the decrease in the number of units shipped against relatively fixed overhead costs.

Operating expenses for the three months ended March 31, 2005 decreased $556,815 from the same period in fiscal 2004. The decrease of $585,296 in sales and marketing expenses was due mainly to a $148,334 decrease in the commissions earned by dealers and employees, a $155,913 decrease in operating supplies, a $47,006 decrease in travel and a $34,037 decrease in advertising, trade shows and sales promotion spending. Administrative expenses decreased by $109,917 mainly due to cost containment efforts such as reducing consulting expenses by $18,304, business insurance premium expense by $20,464, recruiting expenses by $21,373 and building operating expenses by $10,232. Research, development and engineering expenses increased by $138,398.

Total other income for the three months ended March 31, 2005 decreased $10,028 from the same period in fiscal 2004. This reduction was mainly caused by interest expense of $6,064 primarily for a new capital lease (which began in April 2004).

The $556,815 reduction in operating expenses, partially offset by the reduction in gross profit of $379,051 and the decrease in other income of $10,028, resulted in a net loss of $(244,871) for the three months ended March 31, 2005 as compared to a net loss of $(412,607) for the same period in fiscal 2004.

9

CRITICARE SYSTEMS, INC.

Management's Discussion and Analysis of

Results of Operations and Financial Condition

Liquidity and Capital Resources

As of March 31, 2005, the Company had a cash balance of $3,731,417, which was $7,408 lower than its balance at June 30, 2004 of $3,738,825. The Company continues to maintain a long-term bank debt free balance sheet since August 30, 2002 when it sold its building and used the proceeds from the sale to retire the long-term bank debt on the facility.

The Company maintained its cash position for the nine months ended March 31, 2005 as $180,201 and $79,078 of cash used in operations and investing, respectively, was offset by the $294,699 of cash provided from the issuance of common stock, of which $274,275 was provided from the exercise of expiring stock options to purchase a total of 121,900 shares and the remainder represented sales pursuant to the Employee Stock Purchase Plan.

The Company believes all capital and liquidity requirements for the remainder of fiscal 2005 will be satisfied by cash generated from operations and its current cash balances. The Company's $1,000,000 line of credit expires in November 2005. At March 31, 2005 there were no borrowings outstanding under this line of credit.

Forward Looking Statements

A number of the matters and subject areas discussed herein that are not historical or current facts deal with potential future circumstances and developments. These include anticipated product introductions, expected future financial results, liquidity needs, financing ability, management's or the Company's expectations and beliefs and similar matters discussed in Management's Discussion and Analysis or elsewhere herein. The discussions of such matters and subject areas are qualified by the inherent risk and uncertainties surrounding future expectations generally, and also may materially differ from the Company's actual future experience.

The Company's business, operations and financial performance are subject to certain risks and uncertainties which could result in material differences in actual results from management's or the Company's current expectations. These risks and uncertainties include, but are not limited to, general economic conditions, demand for the Company's products, costs of operations, the development of new products, the reliance on single sources of supply for certain components in the Company's products, government regulation, health care cost containment programs, the effectiveness of the Company's programs to manage working capital and reduce costs, competition in the Company's markets, compliance with product safety regulations and product liability and product recall risks, risks relating to international sales and compliance with U.S. export regulations, unanticipated difficulties in outsourcing the manufacturing of the majority of its products to foreign manufacturers and risks related to foreign manufacturing, including economic and political instability, trade and foreign tax laws, production delays and cost overruns and quality control.

10

Quantitative and Qualitative Disclosures about Market Risk

The Company has a demand line of credit facility with a commercial bank with interest payable monthly at 0.25% above the bank's reference rate (6.00% as of March 31, 2005). The Company had no borrowings outstanding under this bank facility at March 31, 2005 and June 30, 2004. Due historically to the lack of need to borrow from this credit facility and due to the Company’s current cash position, the Company is not subject to financial risk on this obligation if interest rates in the market change significantly.

The Company’s net sales are primarily denominated in United States dollars, except for a small amount of net sales from the Company’s operation in India denominated in Indian rupees. As a result, part of the Company’s accounts receivable are denominated in rupees and translated into U.S. dollars for financial reporting purposes. A 10% change in the exchange rate of the U.S. dollar with respect to the Indian rupee would not have a material adverse effect on the Company’s financial condition or results of operations for the quarter ended March 31, 2005. The Company does not use any hedges or other derivative financial instruments to manage or reduce exchange rate risk.

Controls and Procedures

As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and the Company’s Vice President - - Finance, of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on this evaluation, the Company’s Chief Executive Officer and Vice President - Finance concluded that the Company’s disclosure controls and procedures were effective in timely alerting them to material information relating to the Company required to be included in the Company’s periodic filings with the Securities and Exchange Commission. It should be noted that in designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. The Company has designed its disclosure controls and procedures to reach a level of reasonable assurance of achieving the desired control objectives and based upon the evaluation described above, the Company’s Chief Executive Officer and Vice President -Finance concluded that the Company’s disclosure controls and procedures were effective at reaching that level of reasonable assurance.

There was no change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

11

PART II - OTHER INFORMATION

Item 6.Exhibits.

3.1 Restated Certificate of Incorporation of the Company (incorporated by reference to the Registration Statement filed on Form S-1, Registration No. 33-13050).

3.2 By-Laws of the Company (incorporated by reference to the Registration Statement filed on Form S-1, Registration No. 33-13050).

4.1 Specimen Common Stock certificate (incorporated by reference to the Registration Statement filed on Form S-1, Registration No. 33-13050).

4.2 Rights Agreement (incorporated by reference to the Company’s Current Report on Form 8-K filed on April 18, 1997).

31.1 Certification of Emil H. Soika, President and Chief Executive Officer (Principal Executive Officer) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2 Certification of Joel D. Knudson, Vice President - Finance and Secretary (Principal Financial Officer) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32* Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

__________________

* This Certification is not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

12

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CRITICARE SYSTEMS, INC.

(Registrant)

Date: May 12, 2005                                                             BY/s/ Joel D. Knudson                                       

 Joel D. Knudson

 Vice President - Finance

 (Chief Accounting Officer and

 Duly Authorized Officer)

13